← Back to search
ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)
Doing business as SABIN VACCINE INSTITUTE
WASHINGTON, DC, 20006
Unclaimed
Prime contracting experience
3 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. | — | $145,378,689 | Sep 18, 2026 | Sep 26, 2019 – Sep 30, 2027 |
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | STRATEGIC MARBURG ADVANCED RESEARCH AND DEVELOPMENT, PREPAREDNESS, REGISTRATION, EVALUATION AND PROCUREMENT (SMART-PREP) | — | $263,613,186 | Aug 19, 2026 | May 8, 2026 – Apr 30, 2036 |
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE DOSES THAT MAY BE USED IN THE EVENT OF AN OUTBREAK SCENARIO. THE PROPOSED EFFORT WILL UTILI | — | $163,082,416 | May 11, 2026 | Dec 29, 2022 – Sep 30, 2030 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced